Thomas J. Shaw Acquires 12,445 Shares of Retractable Technologies, Inc. (NYSE:RVP) Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw purchased 12,445 shares of the firm’s stock in a transaction that occurred on Monday, January 27th. The stock was bought at an average price of $0.81 per share, with a total value of $10,080.45. Following the transaction, the chief executive officer now directly owns 15,019,308 shares in the company, valued at $12,165,639.48. This trade represents a 0.08 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Retractable Technologies Trading Up 1.9 %

Shares of NYSE RVP opened at $0.82 on Thursday. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01. Retractable Technologies, Inc. has a one year low of $0.56 and a one year high of $1.34. The business has a 50-day moving average price of $0.69 and a two-hundred day moving average price of $0.81. The firm has a market capitalization of $24.42 million, a PE ratio of -1.51 and a beta of 1.94.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on Retractable Technologies in a report on Thursday. They issued a “hold” rating for the company.

Institutional Trading of Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC acquired a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies at the end of the most recent quarter. Institutional investors and hedge funds own 7.58% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.